lazertinib
janssen,yuhan corp,oscotec
['lcsm,(-blcsm)', 'lazertinib']
this could be practice changing now, curious others' opinions: for egfrm+ pt with pd on osi, lazertinib unavailable but not clearly different than osi, do you just continue osi and add amivantamab off-label? #asco22 #lcsm 
Professor and thoracic oncologist @CleClinicMD, TCI Vice Chair Clinical Research, @ASCO #EdBook Assoc Editor, Dad, Steelers fan. All opinions mine. #LCSM